The United States remain a key market for Europe’s life science ecosystem offering significant opportunities for growth, partnerships and commercial development. At the same time, evolving political and economic relations between Europe and the US make it more important than ever to understand the regulatory, legal and practical realities of cross-border business.
At the next Talk in the Cube, we will explore how German life science companies can navigate the US market, establish a presence and build successful transatlantic partnerships.
Whether you are a scientist exploring the commercial potential of your research, a founder preparing to scale your start-up, a life science professional responsible for international expansion, an investor or a representative of a research institution, join us to discuss the opportunities, challenges and practical steps involved in strengthening connections between the European and US life science ecosystems. Bring your questions, share your perspective and network with us over snacks and drinks.
With insights from legal and business experts, we plan to tackle practical aspects that arise when turning scientific innovation into US business such as
- Setting up a business in the US: Key considerations when establishing a US entity and choosing the right corporate structure
- Immigration and employment law: What German companies need to know when building teams and operating across borders
- Product liability and risk management: Legal considerations for life science and pharmaceutical companies bringing products to the US market
- Market entry and business development: How the German American Chamber of Commerce (AHK) supports companies entering the US market
A Panel Discussion with
Juliane Eichler, LL.M., Director of the Legal Department at the German American Chamber of Commerce, New York,
Julian Schröder, Head of Group Controlling at Eckert & Ziegler SE, Berlin,
Uwe Lohmeier, Head Berlin BioScience Academy (BBA), Campus Berlin-Buch GmbH (Moderation).
Juliane Eichler
is the Director of the Legal Department at the German American Chamber of Commerce (AHK) USA–New York. Ms. Eichler studied law at Ludwig Maximilian University in Munich and at Emory Law School in Atlanta. She is a fully qualified lawyer in Germany and admitted to practice as an Attorney-at-Law in the states of New York and Texas. For several years, she has been supporting German companies with their market entry into the United States.
AHK – New York
The German American Chamber of Commerce, Inc. (GACC NY) was established more than 75 years ago in New York City as an impartial promoter of commerce between Germany and the US. The organization has distinguished itself as an innovative and relevant service provider as well as a reliable partner in German-American business inquiries. Comprised of a highly qualified team of professionals, the GACC NY supports companies by facilitating the following: market entry & business development, legal services, intern visas, recruitment and startup guidance.
Julian Schröder
Head of Group Controlling, Eckert & Ziegler SE, holds a master’s degree in International Business from Maastricht University and joined Eckert & Ziegler in 2013. He held various positions within the group before becoming Head of Group Controlling in 2021. In 2025, he was appointed Member of the Group Executive Committee representing Finance and Controlling
Eckert & Ziegler SE
The Eckert & Ziegler Group is one of the world’s largest providers of isotope technology for medical, scientific and industrial use. Eckert & Ziegler was founded in 1997 as a holding company. The oldest subsidiary, Eckert & Ziegler BEBIG GmbH, was preceded by the Zentralinstitut für Isotopentechnik, a research institute of the former Academy of Sciences of the GDR. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Börse.
Target audience
Founders & scientists from start-ups, small and medium-sized life science companies and scientific institutions.
Costs
Participation is free of charge. Registration is requested.
When
Thursday, 12 November 2026
5:00 p.m. – 7:00 p.m.
Where
BerlinBioCube (Building D95), Campus Berlin-Buch, Robert-Rössle-Straße 10, 13125 Berlin
Further information
Uwe Lohmeier per E-Mail: u.lohmeier@campusberlinbuch.de
About "Talk in the Cube"
With the event series "Talk in the Cube", we bring business and science together on the Berlin-Buch campus and connect founders of start-ups or life science companies with scientists, e.g. from the Max Delbrück Center, FMP, Charité and BIH. Talk in the Cube offers an opportunity to gain practical insights, exchange perspectives and connect with the Berlin life science community. We invite experts on business topics or trends in the life sciences and highlight aspects such as
What innovations are there in the start-ups and who is driving them forward?
How does the life science business world work and where can synergies with science be created?
How does the "networked laboratory" and AI can work together in life science?
About the Berlin BioScience Academy "BBA"
The Berlin BioScience Academy (BBA), formerly known as "Gläsernes Labor Akademie (GLA)", supports young scientists throughout Germany in their professional orientation and entry into the pharmaceutical and biotechnology industry. It offers technical assistants and laboratory technicians in-service training on current topics in the life sciences. Our focus is on a close connection between science and business. It enables the conception, certification and implementation of a practice-oriented continuing training program with a top-class team of experts from research institutions and industry. The life science program includes summer schools, laboratory courses, seminars, webinars and congresses. In addition, the BBA invites to the "Talks in the Cube" at the BerlinBioCube. The talks regularly inform about "hot topics" in Biotech & Biomedicine and provide the campus network forum for biotech companies, research institutions, investors and associations.
About Campus Berlin-Buch GmbH
Campus Berlin-Buch GmbH (CBB) is developing the international campus together with the research institutions Max Delbrück Center for Molecular Medicine in the Helmholtz Association (Max Delbrück Center) and the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) as an innovative and sustainable science and technology location.
As an economically independent, non-profit company with a public mandate, Campus Berlin-Buch GmbH is a neutral and intermediary partner. It serves as the interface to basic research, clinical research, companies, administration, policymakers in government and the general public and is engaged in competence networks as well as support and service networks on a regional and international level.
Version: 20 October 2026
Subject to modifications